Aska PharmaceuticalLtd. (4886.TSE) Q3 2024 Earnings

5AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
40
55
71
87

Details

Expected EPS
40
Actual EPS
41
Surprise EPS
1
Surprise Percent
+2.63%

Description

Aska PharmaceuticalLtd. (4886.TSE) has reported earnings of 41 per share for Q3 2024.

0 Comments

Share your thoughts